Functional magnetic resonance imaging and schizophrenia: Medication effects, methodological limitations and perspectives;Funktionelle kernspintomographie und schizophrenia: Medikamenteneffekte, methodische grenzen und perspektiven

Nervenheilkunde

Volumn 19, Issue 3, 2000, Pages 121-128

  Braus, D F ^a,b   Ende, Gabriele ^a   Tost, Heike ^a   Weber Fahr, W ^a   Jatzko, A ^a   Schmitt, Andrea ^a   Demirakca, Traute ^a   Ruf, M ^a  

^a NMR Forschung   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

fMRI; Functional magnetic resonance imaging; Medication effects; MR spectroscopic imaging; MRSI; Schizophrenia

Indexed keywords

N ACETYLASPARTIC ACID; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PHENOTYPE; PREFRONTAL CORTEX; PSYCHOMETRY; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; SYMPTOMATOLOGY; THALAMUS;

EID: 0034117638     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Andreasen NC. A unitary model of schizophrenia. Bleuler's »fragmented phrene« as schizencephaly.Arch Gen Psychiatry 1999; 56: 781-7.
2. Bertolino A, Esposito G, Callicott JH, Mattay VS, Van Horn JD, Frank JA, Berman KF, Weinberger DR. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry 2000; 157: 26-33.
3. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT, Frank JA, Tedeschi G, Weinberger DR. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1996; 153: 1554-63.
4. Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav 1989; 13: 23-31.
5. Braff DL, Geyer MA. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 1990; 47: 181-8.
6. Braus DF, Ende G, Ruf M, Hubrich-Ungureanu P, Henn FA. Disturbed frontal network in neuroleptic-naive patients with first break schizophrenia: a fMRI study. Eur Arch of Psychiatry Clin Neurosci 1998; 238: 139.
7. Braus DF, Ende G, Sartorius A, Krier A, Ruf M, Weber-Fahr W, Henn FA. Differential effects of atypicals versus neuroleptics: an fMRI and MRSI study in schizophrenic patients. Proc ISMRM 1998; 3: 1589.
8. Braus DF, Ende G, Sartorius A, Krier A, Stuck S, Henn FA. Atypical vs. typical neuroleptics: a combined fMRI and MRSI study in schizophrenic patients. Eur Arch of Psychiatry Clin Neurosci 1998; 238: 138.
9. Braus DF, Ende G, Weber-Fahr W, Sartorius A, Hubrich-Ungureanu P, Ruf M, Stuck S, Henn FA. Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients. Schizophr Res 1999; 39: 19-29.
10. Braus DF, Rindfleisch J, Nguyen XP, Kirsch P, Sartorius A, Krier A, Ende G, Zwick A, Henn FA. Monitoring EEG data during echo planar fMRI. MAGMA 1996; 4: 328.
11. Buckley PF, Friedman L, Wu D, Lai S, Meltzer HY, Haacke EM, Miller D, Lewin JS. Functional magnetic resonance imaging in schizophrenia: Initial methodology and evaluation of the motor cortex. Psychiatry Res Neuroimaging 1997; 74: 13-23.
12. Buckner RL, Bandettini PA, O'Craven KM, Savoy RL, Petersen SE, Raichle ME, Rosen BR. Detection of cortical activation during averaged single trials of a cognitive task using functional magnetic resonance imaging. Proc Natl Acad Sci USA 1996; 93: 14878-83.
13. Callicott JH Ramsey NF, Tallent K, Bertolino A, Knable MB, Coppola R, Goldberg T, van Gelderen P, Mattay VS, Frank JA Moonen CT, Weinberger DR. Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology 1998; 18: 186-96.
14. David AS, Woodruff PW, Howard R, Mellers JD, Brammer M, Bullmore E, Wright I, Andrew C, Williams SC. Auditory hallucinations inhibit exogenous activation of auditory association cortex. Neuroreport 1996; 7: 932-6.
15. De Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995; 34: 721-7.
16. Dierks T, Linden DE, Jandl M, Formisano E, Goebel R, Lanfermann H, Singer W. Activation of Heschl's gyrus during auditory hallucinations. Neuron 1999; 22: 615-21.
17. Duncan JS. Magnetic resonance spectroscopy. Epilepsia 1996; 37: 598-605.
18. 1H MRSI study in schizophrenic patients. Proc ISMRM 1998; 1: 502.
19. Friston KJ, Holmes AP, Poline JB, Grasby PJ, Williams SC, Frackowiak RS, Turner R. Analysis of fMRI time-series revisited. Neuroimage 1995; 2: 45-53.
20. Friston KJ, Josephs O, Rees G, Turner R. Non-linear event-related responses in fMRI. magn Reson Med 1998; 39: 41-52.
21. Gadian DD. NMR and its application to living systems. 2. Aufl., Oxford; New York; Tokyo Oxford University Press 1995.
22. Gaser C, Volz HP, Kiebel S, Riehemann S, Sauer H. Detecting structural changes in whole brain based on nonlinear deformations-application to schizophrenia research. Neuroimage 1999; 10: 107-13.
23. Goebel R, Khorram-Sefat D, Muckli L, Hacker H, Singer W. The constructive nature of vision: direct evidence from functional magnetic resonance imaging studies of apparent motion and motion imagery. Eur J Neurosci 1998; 10: 1563-73.
24. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153: 321-30.
25. Green MF, Marshall BD, Jr., Wirshing WC, Ames D, Marder SR, McGurk S, Kern RS, Mintz J. Does risperidone improve verbal working memory in treatment-resistant schizophrenia? Am J Psychiatry 1997; 154: 799-804.
26. Hazlett EA. Buchsbaum MS, Byne W, Wei TC, Spiegel-Cohen J, Geneve C, Kinderlehrer R, Haznedar MM, Shihabuddin L, Siever LJ. Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. Am J Psychiatry 1999; 156: 1190-9.
27. Holzman PS. Recent studies of psychophysiology in schizophrenia. Schizophr Bull 1987; 13: 49-75.
28. Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci USA 1999; 96: 13432-7.
29. Jentsch JD, Redmond DE, Jr., Elsworth JD, Taylor JR, Youngren KD, Roth RH. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science 1997; 277: 953-5.
30. Lemieux L, Allen PJ, Franconi F, Symms MR, Fish DR. Recording of EEG during fMRI experiments: patient safety. Magn Reson Med 1997; 38: 943-52.
31. Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry 1999; 56: 367-74.
32. Mattay VS, Callicott JH, Bertolino A, Santha AK, Tallent KA, Goldberg TE, Frank JA, Weinberger DR. Abnormal functional lateralization of the sensorimotor cortex in patients with schizophrenia. Neuroreport 1997; 8: 2977-84.
33. Maurer K, Hafner H. Methodological aspects of onset assessment in schizophrenia. Schizophr Res 1995; 15: 265-76.
34. Meltzer HY, Lee MA, Ranjan R. Recent advances in the pharmacotherapy of schizophrenia. Acta Psychiatr Scand Suppl 1994; 384: 95-101.
35. Northoff G, Braus DF, Sartorius A, Khoram-Sefat D, Russ M, Eckert J, Herrig M, Leschinger A, Bogerts B, Henn FA. Reduced activation and altered laterality in two neuroleptic-naive catatonic patients during a motor task in functional MRI. Psych Med 1999; 29: 997-1002.
36. Ogawa S, Menon RS, Tank DW, kim SG, Merkle H, Ellermann JM, Ugurbil K. Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. Biophys J 1993; 64: 803-12.
37. Ogawa S, Tank DW, Menon R, Ellermann JM, Kim SG, Merkle H, Ugurbil K. Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci USA 1992; 89: 5951-5.
38. Posner MI, Petersen SE, Fox PT, Raichle ME. localization of cognitive operations in the human brain. Science 1988; 240: 1627-31.
39. Schroeder J, Wenz F, Schad LR, Baudendistel K, Knopp MV. Sensorimotor cortex and supplementary motor area changes in schizophrenia. A study with functional magnetic resonance imaging. Br J Psychiatry 1995; 167: 197-201.
40. Spitzer M, Kischka U, Guckel F, Bellemann ME, Kammer T, Seyyedi S, Weisbrod M, Schwartz A, Brix G. Functional magnetic resonance imaging of category-specific cortical activation: evidence for semantic maps. Brains Res Cogn Brain Res 1998; 6: 309-19.
41. Stehling MK, Turner R, Mansfield P. Echo-planar imaging: magnetic resonance imaging in a fraction of a second. Science 1991; 254: 43-50.
42. Volz HP, Gaser C, Hager F, Rzanny R, Mentzel HJ, Kreitschmann-Andermahr I, Kaiser WA, Sauer H. Brain activation during cognitive stimulation with the Wisconsin Card Sorting Test - a functional MRI study on healthy volunteers and schizophrenics. Psychiatry Res 1997; 75: 145-57.
43. Weinberger DR, Gallhofer B. Cognitive function in schizophrenia. Int Clin Psychopharmacol 1997; 12 (Suppl 4): 29-36.
44. Weiss AP, Heckers S. Neuroimaging of hallucinations: a review of the literature. Psychiatry Res: Neuroimaging 1999; 92: 61-74.
45. Wenz F, Schad LR, Knopp MV, Baudendistel KT, Flomer F, Schroder J, van Kaick G. Functional magnetic resonance imaging at UT: activation pattern in schizophrenic patients receiving neuroleptic medication. Magn Reson Imaging 1994; 12: 975-82.
46. Woodruff P, Brammer M, Mellers J, Wright I, Bullmore E, Williams S. Auditory hallucinations and perception of external speech. Lancet 1995; 346: 1035.
47. Yurgelun-Todd DA, Waternaux CM, Cohen BM, Gruber SA, English CD, Renshae PF. Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. Am J Psychiatry 1996; 153: 200-5.